- Release Date: 26/05/25 08:22
- Summary: Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial
- Price Sensitive: Yes
- Download Document 204.99KB
- Forums
- ASX - By Stock
- IMM
- Ann: Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial
IMM
immutep limited
Add to My Watchlist
7.69%
!
28.0¢

Ann: Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.0¢ |
Change
0.020(7.69%) |
Mkt cap ! $407.3M |
Open | High | Low | Value | Volume |
25.5¢ | 28.3¢ | 25.5¢ | $631.1K | 2.312M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 279856 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 22173 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 124959 | 0.280 |
14 | 238228 | 0.275 |
12 | 357798 | 0.270 |
9 | 133472 | 0.265 |
13 | 513579 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 562057 | 29 |
0.290 | 431180 | 15 |
0.295 | 140669 | 7 |
0.300 | 241419 | 9 |
0.305 | 47087 | 3 |
Last trade - 12.25pm 07/08/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |